Shannon Khal

ORCID: 0000-0003-4477-0448
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Treatments and Mutations
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Nanoparticle-Based Drug Delivery
  • Cancer Mechanisms and Therapy
  • Chronic Myeloid Leukemia Treatments
  • RNA Interference and Gene Delivery

Centralia College
2021

Providence College
2021

Oregon State University
2016

We report an efficient therapeutic modality for platinum resistant ovarian cancer based on siRNA-mediated suppression of a multifunctional DJ-1 protein that is responsible the proliferation, growth, invasion, oxidative stress, and overall survival various cancers. The developed strategy can work alone or in concert with low dose first line chemotherapeutic agent cisplatin, to elicit maximal response. To achieve knockdown, we constructed polypropylenimine dendrimer-based nanoplatform targeted...

10.1021/acs.molpharmaceut.6b00205 article EN Molecular Pharmaceutics 2016-05-12

10.1177/10781552211016078 article EN Journal of Oncology Pharmacy Practice 2021-05-20
Coming Soon ...